SKI Market

A+| A| A-|

Indian Indices

Sensex

75,073.03 297.29
( 0.40%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

38.91

15431.13

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.2

Back

SGL Resources consolidated net profit declines 10.20% in the September 2025 quarter

Nov 21,2025

Net profit of SGL Resources declined 10.20% to Rs 0.44 crore in the quarter ended September 2025 as against Rs 0.49 crore during the previous quarter ended September 2024. Sales rose 81.86% to Rs 39.19 crore in the quarter ended September 2025 as against Rs 21.55 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	39.19	21.55	82
OPM %	1.94	89.98	-
PBDT	2.67	0.96	178
PBT	0.64	0.67	-4
NP	0.44	0.49	-10

75,073.03 297.29 ( 0.40%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)